Plus, Zscaler largely delivers for its owners with its latest results.
And It comes after one of the best days of the year for the biotech sector.
The shares of the under-the-radar biotech have had a strong run in recent months, so traders might want to watch for a pullback to buy.
Incompetence, omissions and even outright lies have categorized this federal attempt to 'stem' the pandemic.
This COVID-19 vaccine is the potential savior of more than just the market.
We're seeing a group move in pharma right now, so let's sort it out, pill by pill.
The shares are only trading at 17 times forward earnings, and might not be fully valued just yet.
A subscriber asks. We answer.
Recent news about Travelzoo and Albireo Pharma offer reasons to think those shares could be heading higher.